GENERIC NAME: Anti-tetanus serum
BRAND NAME: Tetanus Toxoid
GENERAL CLASSIFICATION: EPI vaccine, Anti-tetanus
Tetanus Toxoid is indicated for booster injection only for persons 7 yrs of age and older against tetanus.
Primary immunization schedule for children under 7 yrs of age should consist of five doses of vaccine containing tetanus toxoid.
Tetanus Toxoid is not to be used for treatment of tetanus infection.
As with any vaccine, vaccination with tetanus toxoid may not protect 100% of susceptible individuals. DOSAGES:
After the initial immunization series is completed, a booster dose of 0.5mL of tetanus toxoid should be given intramuscularly every 10 yrs to maintain adequate immunity. SIDE EFFECT/ ADVERSE REACTION:
Body System as a whole:
Redness, warmth, edema, induration with or without tenderness as well as urticaria, and rash. Malaise, transient fever, pain, hypotension, nausea, and arthralgia NURSING CONSIDERATION:
Shake well the vial before withdrawing each dose
Special care should be taken to ensure that the injection does not enter the blood vessel
For Nursing Mothers:
Tetanus Toxoid does not affect the safety of mothers who are breastfeeding or their infants. Breastfeeding does not adversely affect immune response and is not a contraindication for vaccination
For Pediatric Use:
Safety and effectiveness of tetanus toxoid in infants below the age of 6 weeks has not been established. However, this vaccine is not indicated for children under 7 yrs of age.
For Geriatric Use:
Tetanus Toxoid should only be used in geriatric patients known to have received a primary series of tetanus-containing vaccine, since many such as persons have no prior immunity.
GENERIC NAME: Rabies vaccine
BRAND NAME: Verorab
GENERAL CLASSIFICATION: Anti-rabies vaccine
All subjects at a permanent risk should be vaccinated
A serological test is recommended every 6 months
Please join StudyMode to read the full document